世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の肺がん治療l市場

Global Lung Cancer Therapeutics Market

 

出版社 出版年月電子版価格 ページ数
Market Litmus
マーケットリトマス
2018年7月US$3,850
シングルユーザライセンス
210

サマリー

この調査レポートは世界の肺がん治療l市場詳細に調査・分析したMarket Litmusの市場調査報告書です。

Overview

In today's world, with the growing urbanization, air pollution is one of the major reasons for concern regarding people's health concerns. One of the major diseases that is getting prevalence, mostly among the developed countries is lung cancer. This is giving rise to the therapeutics market for lung cancer. Also, the developing markets are having increasing concerns about this disease and therefore, the therapeutics market is expected to develop rapidly.

End-User/Technology

The end-users are mostly older people although, with the current scenario of rapid urbanization, the occurrence among younger people is expected to show a growth trajectory. Also, because of the developed healthcare infrastructure and better awareness, most of the people are from developed countries as the reporting of such cases becomes easier.

The research is going on with the primary target of developing more efficient solutions and at a much lower price so that the scope of this market reaches beyond the developed in more developing countries which have a very high expected growth potential. Also, technologies like multiplex genotyping and next-generation sequencing are expected to bring about radical changes in the market.

Market Dynamics

Increasing pollution, especially in the rapidly developing Asia Pacific region has led to increased cases of lung cancer. But at the same time, due to increasing awareness and betterment of healthcare infrastructure, the reporting and identification has become more efficient and has led to the growth of this market. Also, due to better manufacturing procedures, coming of new patents and increasing emphasis on enhancing affordability and effectiveness, people are becoming more acceptable towards the treatment procedures, even in the developing countries. Research in this field going on extensively and hence is expected to bring about new and better products in the near future.

Market Segmentation

The segmentation for the market is done both on the basis of the products as well as the people. The product segmentation may include the availability of generic medicines and the level of advancement of the therapeutics itself in curing the disease. On the basis of people, the changing lifestyle of people is playing an important factor and therefore, not only segmentation on the basis of age but also in terms of habits and demographics is playing an important role in judging this market.

Regional/Geographic Analysis

On the basis of geography, developed countries like the United States of America and European countries have a higher prevalence rate of lung cancer due to early industrialization and aging population. Also, these countries have a very developed healthcare infrastructure which makes the identification easier. The Asia Pacific region is expected to be a lucrative market with the research going on for making the therapeutics more affordable and efficient.

Opportunities

There is a myriad of opportunities based on the how fast the products are made affordable enough for the developing economies of the world. Moreover, the betterment of healthcare infrastructure plays a major role in the timely identification of the disease and hence, may ensure a larger consumer base.

Key Players

The key players operating in the market are GlaxoSmithKline, Pfizer, Merck, Novartis Oncology and so on.

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada


> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America


> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe


> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe


> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific


> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa



This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage



目次

目次はデータリソースまでお申し付けください。

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る